{"id":4413,"date":"2019-06-05T17:44:24","date_gmt":"2019-06-05T15:44:24","guid":{"rendered":"https:\/\/arsys.arser.org\/arser\/?p=4413"},"modified":"2022-03-15T12:27:32","modified_gmt":"2022-03-15T11:27:32","slug":"medicament-clastoban","status":"publish","type":"post","link":"https:\/\/arsys.arser.org\/arser\/medicament-clastoban\/","title":{"rendered":"M\u00e9dicament CLASTOBAN 800 mg \u00e0 nouveau disponible"},"content":{"rendered":"<p>Fin mai 2019, le Laboratoire BioProjet nous a annonc\u00e9 que, dans toutes les pharmacies de ville,\u00a0<strong>le CLASTOBAN 800 mg, soluble, est \u00e0 nouveau disponible,\u00a0<\/strong>alors qu&rsquo;il \u00e9tait en rupture de fabrication depuis d\u00e9cembre 2017.<\/p>\n<p>Une tr\u00e8s bonne nouvelle pour tous les patients sous traitement PENTOCLO, en particulier pour ceux qui ont des pathologies ORL (ost\u00e9oradion\u00e9crose), donc des difficult\u00e9s \u00e0 avaler.<\/p>\n<p style=\"text-align: center;\">____________________________________________<\/p>\n<p>Le compte-rendu de l\u2019assembl\u00e9e g\u00e9n\u00e9rale de l\u2019ARSER du 25 mai 2019 est disponible.\u00a0Si vous ne l\u2019avez pas re\u00e7u, n\u2019h\u00e9sitez pas \u00e0 le demander en \u00e9crivant \u00e0 :\u00a0<a href=\"mailto:ecrire.arser@gmail.com\">ecrire.arser@gmail.com<\/a><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Fin mai 2019, le Laboratoire BioProjet nous a annonc\u00e9 que, dans toutes les pharmacies de ville,\u00a0le CLASTOBAN 800 mg, soluble, est \u00e0 nouveau disponible,\u00a0alors qu&rsquo;il \u00e9tait en rupture de fabrication depuis d\u00e9cembre 2017. Une tr\u00e8s bonne nouvelle pour tous les patients sous traitement PENTOCLO, en particulier pour ceux qui ont des pathologies ORL (ost\u00e9oradion\u00e9crose), donc &hellip; <a href=\"https:\/\/arsys.arser.org\/arser\/medicament-clastoban\/\" class=\"more-link\">Continuer la lecture<span class=\"screen-reader-text\"> de &laquo;&nbsp;M\u00e9dicament CLASTOBAN 800 mg \u00e0 nouveau disponible&nbsp;&raquo;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0},"categories":[9],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/posts\/4413"}],"collection":[{"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/comments?post=4413"}],"version-history":[{"count":14,"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/posts\/4413\/revisions"}],"predecessor-version":[{"id":11142,"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/posts\/4413\/revisions\/11142"}],"wp:attachment":[{"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/media?parent=4413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/categories?post=4413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsys.arser.org\/arser\/wp-json\/wp\/v2\/tags?post=4413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}